Vaccines Market Report – Research, Industry Analysis Reports and Market Demands

Global Vaccines Market Growth 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Vaccines Consumption Market Report

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Vaccines Consumption 2014-2024
- 2.1.2 Vaccines Consumption CAGR by Region
2.2 Vaccines Segment by Type
- 2.2.1 Recombinant Vaccines
- 2.2.2 Viral Vaccines
- 2.2.3 Polysaccharide Vaccines
- 2.2.4 Others
2.3 Vaccines Consumption by Type
- 2.3.1 Global Vaccines Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Vaccines Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Vaccines Sale Price by Type (2014-2019)
2.4 Vaccines Segment by Application
- 2.4.1 Cholera
- 2.4.2 Hepatitis B
- 2.4.3 Diphtheria
- 2.4.4 Tetanus
- 2.4.5 Measles vaccine
- 2.4.6 Hepatitis A
- 2.4.7 Live attenuated influenza vaccine
- 2.4.8 Polio vaccine
- 2.4.9 Rabies vaccine
- 2.4.10 Others
2.5 Vaccines Consumption by Application
- 2.5.1 Global Vaccines Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Vaccines Value and Market Share by Application (2014-2019)
- 2.5.3 Global Vaccines Sale Price by Application (2014-2019)

3 Global Vaccines by Players

3.1 Global Vaccines Sales Market Share by Players
- 3.1.1 Global Vaccines Sales by Players (2017-2019)
- 3.1.2 Global Vaccines Sales Market Share by Players (2017-2019)
3.2 Global Vaccines Revenue Market Share by Players
- 3.2.1 Global Vaccines Revenue by Players (2017-2019)
- 3.2.2 Global Vaccines Revenue Market Share by Players (2017-2019)
3.3 Global Vaccines Sale Price by Players
3.4 Global Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Vaccines Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Vaccines Products Offered
3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Vaccines by Regions

4.1 Vaccines by Regions
- 4.1.1 Global Vaccines Consumption by Regions
- 4.1.2 Global Vaccines Value by Regions
4.2 Americas Vaccines Consumption Growth
4.3 APAC Vaccines Consumption Growth
4.4 Europe Vaccines Consumption Growth
4.5 Middle East & Africa Vaccines Consumption Growth

5 Americas

5.1 Americas Vaccines Consumption by Countries
- 5.1.1 Americas Vaccines Consumption by Countries (2014-2019)
- 5.1.2 Americas Vaccines Value by Countries (2014-2019)
5.2 Americas Vaccines Consumption by Type
5.3 Americas Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Vaccines Consumption by Countries
- 6.1.1 APAC Vaccines Consumption by Countries (2014-2019)
- 6.1.2 APAC Vaccines Value by Countries (2014-2019)
6.2 APAC Vaccines Consumption by Type
6.3 APAC Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Vaccines by Countries
- 7.1.1 Europe Vaccines Consumption by Countries (2014-2019)
- 7.1.2 Europe Vaccines Value by Countries (2014-2019)
7.2 Europe Vaccines Consumption by Type
7.3 Europe Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Vaccines by Countries
- 8.1.1 Middle East & Africa Vaccines Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Vaccines Value by Countries (2014-2019)
8.2 Middle East & Africa Vaccines Consumption by Type
8.3 Middle East & Africa Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
10.2 Vaccines Distributors
10.3 Vaccines Customer

11 Global Vaccines Market Forecast

11.1 Global Vaccines Consumption Forecast (2019-2024)
11.2 Global Vaccines Forecast by Regions
- 11.2.1 Global Vaccines Forecast by Regions (2019-2024)
- 11.2.2 Global Vaccines Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
11.7 Global Vaccines Forecast by Type
11.8 Global Vaccines Forecast by Application

12 Key Players Analysis

13 Research Findings and Conclusion

Description

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Vaccines can be divided into recombinant vaccines, viral vaccines, polysaccharide vaccines and others. Recombinant vaccines and viral vaccines contain many kinds of vaccines, and the demand is larger than others kinds. But with the development of new technologies, more and more new types of vaccines will be popularized. The scope for disease prevention will be enlarged .The demand of other kinds is also increasing.
China is the fastest growing Vaccines market in the world thanks to positive policy and increasing market awareness.
Average industry gross margin is about 76.95%. But due to high requirement for funds and technology, before investment you'd better take a deep consideration. So far many large companies choose cooperation or acquisition to achieve the expansion of business.

According to this study, over the next five years the Vaccines market will register a 6.2% CAGR in terms of revenue, the global market size will reach US$ 50900 million by 2024, from US$ 35400 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines market by product type, application, key manufacturers and key regions and countries.

This study considers the Vaccines value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Cholera
Hepatitis B
Diphtheria
Tetanus
Measles vaccine
Hepatitis A
Live attenuated influenza vaccine
Polio vaccine
Rabies vaccine
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Vaccines market by identifying its various subsegments.
Focuses on the key global Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.